Today: 27 April 2026
Browse Category

Stock Market 10 February 2026

Chevron stock slips as Tengiz field ramps back up, oil traders eye Iran risk

Chevron stock slips as Tengiz field ramps back up, oil traders eye Iran risk

Chevron shares slipped 0.3% to $182.08 in midday trading as the Tengiz oilfield in Kazakhstan, led by Chevron, recovered to 60% of peak output after January fires. Tengiz aims to reach 950,000 barrels per day by Feb. 23, up from 550,000 bpd on Feb. 8, according to industry sources. Oil prices held steady. Traders are awaiting U.S. inventory data and further updates on Tengiz.
10 February 2026
····
ServiceNow stock rebounds nearly 4% as AI-fueled software jitters ease — for now

ServiceNow stock rebounds nearly 4% as AI-fueled software jitters ease — for now

ServiceNow shares climbed 3.6% to $107.66 Tuesday after recent sharp declines, as software stocks rebounded from last week’s selloff. Retail inflows into BlackRock’s tech-software ETF reached a record $176 million, even as the S&P 500 software index remains down 13% since late January. Broader markets were mixed following flat December U.S. retail sales data. Datadog rose after beating quarterly estimates but issued cautious full-year guidance.
10 February 2026
··
KLA stock price dips: KLAC slips as investors size up India R&D hub push and chip-tool outlook

KLA stock price dips: KLAC slips as investors size up India R&D hub push and chip-tool outlook

KLA Corp shares fell 0.6% to $1,431 in late-morning New York trading Tuesday, trailing the semiconductor ETF. The company announced a new R&D and innovation hub in Chennai, India, to support AI and engineering. Investors are watching for peer earnings later this week and KLA’s dividend timetable, with a $1.90-per-share payout set for March 3.
10 February 2026
···
GE Vernova stock slips from recent highs after 2030 turbine slot deal — what GEV investors watch next

GE Vernova stock slips from recent highs after 2030 turbine slot deal — what GEV investors watch next

GE Vernova shares slipped 0.7% to $796.29 in late-morning New York trading after Maxim Power reserved a 7HA.02 gas turbine slot for 2030 delivery, with a non-refundable deposit due in 2026. The broader market edged higher, while GE Vernova also reported upgrades at InterGen’s Coryton plant in the UK. Investors await the company’s April 22 earnings webcast.
10 February 2026
··
UnitedHealth stock price today: UNH ticks up as Medicare Advantage rate clock and ACA probes hang over insurers

UnitedHealth stock price today: UNH ticks up as Medicare Advantage rate clock and ACA probes hang over insurers

UnitedHealth shares rose 0.8% to $278.04 Tuesday after a volatile open, as investors watched Medicare Advantage payment updates and new federal scrutiny of health insurers. The Centers for Medicare & Medicaid Services projected a 0.09% average payment increase for 2027, with final rates due by April 6. House Republicans subpoenaed eight ACA insurers in a subsidy fraud probe; UnitedHealth was not named. Managed care stocks were mixed.
10 February 2026
·
Hims & Hers stock price slides again as Novo Nordisk lawsuit tightens the screws on Wegovy copies

Hims & Hers stock price slides again as Novo Nordisk lawsuit tightens the screws on Wegovy copies

Hims & Hers Health shares fell 5.6% to $18.25 Tuesday after Novo Nordisk filed a U.S. patent lawsuit seeking to block sales of compounded versions of its Wegovy weight-loss drug. The FDA has said semaglutide is no longer in shortage, tightening rules on compounding. Hims pulled its $49 compounded semaglutide pill days after launch. Investors await Hims’ earnings on Feb. 23.
10 February 2026
···
Booking Holdings stock price rebounds on Gordon Haskett upgrade as BKNG eyes Feb. 18 earnings

Booking Holdings stock price rebounds on Gordon Haskett upgrade as BKNG eyes Feb. 18 earnings

Booking Holdings shares climbed nearly 3% Tuesday after Gordon Haskett upgraded the stock to “buy” with a $5,440 price target. The rebound follows a 5% drop Monday; shares remain well below their July 2025 high. Investors await Booking’s quarterly results and conference call on Feb. 18. Trading volume was above average, with the stock lagging travel peers the previous session.
10 February 2026
··
Intapp stock price jumps as software rebound returns; Feb 25 Investor Day in focus

Intapp stock price jumps as software rebound returns; Feb 25 Investor Day in focus

Intapp shares rose 7.7% to $26.25 in New York trading after last week’s software selloff. The iShares Expanded Tech-Software ETF gained 2% as retail inflows hit a record $176 million, according to Vanda Research. Intapp reported SaaS revenue of $102.5 million and announced a new $200 million share buyback. Investors await Intapp’s Feb. 25 Investor Day for updates on its AI strategy.
10 February 2026
·
Flutter Entertainment stock price today: FLUT edges up as UBS cuts target and prediction markets loom

Flutter Entertainment stock price today: FLUT edges up as UBS cuts target and prediction markets loom

Flutter shares rose 0.6% to $155.48 Tuesday morning after UBS cut its price target to $300 but kept a buy rating. The move comes as investors track competition from prediction markets and await Flutter’s fourth-quarter results on Feb. 26. Massachusetts regulators are challenging prediction markets, with Polymarket suing the state attorney general. Flutter’s stock recently ended an eight-week losing streak.
10 February 2026
·
CoreWeave stock slips as lawsuit notices and insider-sale filing hit a hot trade

CoreWeave stock slips as lawsuit notices and insider-sale filing hit a hot trade

CoreWeave shares fell 2% to $94.84 Tuesday, reversing part of Monday’s gain, after a class-action notice and insider-related SEC filing circulated. An entity linked to co-founder Brannin McBee filed to sell shares, while law firms urged investors to join a proposed lawsuit over infrastructure delays. Investors await CoreWeave’s Feb. 26 earnings for updates on capacity and funding. The broader tech sector was steady.
10 February 2026
FMC stock price jumps nearly 7% as traders weigh strategic review and fresh Citi target cut

FMC stock price jumps nearly 7% as traders weigh strategic review and fresh Citi target cut

FMC shares jumped 7% to $16.46 Tuesday morning, extending gains after the company launched a strategic review that could include a sale and warned of weaker 2026 results. Citigroup cut its price target to $14 but kept a Neutral rating. Moody’s downgraded FMC’s debt to junk, citing increased event risk. The company’s annual shareholder meeting is set for April 28.
10 February 2026
·
Lumentum stock price drops as rally cools — here’s what traders watch next

Lumentum stock price drops as rally cools — here’s what traders watch next

Lumentum shares fell 2.4% to $563.33 Tuesday morning after a strong prior session, swinging between $531 and $579 as major indexes edged up. The drop follows a recent rally tied to AI and cloud data-center spending. Last week, Lumentum reported Q2 revenue of $665.5 million and forecast Q3 revenue up to $830 million. Management will appear at tech conferences on Feb. 26 and March 2.
10 February 2026
·
MongoDB stock jumps 6% as Morgan Stanley flags cloud demand rebound ahead of March earnings

MongoDB stock jumps 6% as Morgan Stanley flags cloud demand rebound ahead of March earnings

MongoDB shares rose 6.3% to $380.32 Tuesday morning on Nasdaq, rebounding from an early drop amid renewed interest in cloud software stocks. Morgan Stanley and Goldman Sachs issued notes downplaying AI disruption fears and projecting revenue upside. Investors await MongoDB’s quarterly results due March 2 for updates on Atlas usage and revenue trends. Snowflake and Datadog also traded higher.
10 February 2026
····
Exxon Mobil stock slips from fresh high as oil steadies and U.S. data looms

Exxon Mobil stock slips from fresh high as oil steadies and U.S. data looms

Exxon Mobil shares slipped 0.5% to $150.49 Tuesday morning after hitting a 52-week high at $151.21 on Monday. Oil prices were little changed, with Brent at $69.31 and WTI at $64.48 as traders watched U.S.-Iran tensions and awaited U.S. inventory data. Chevron and ConocoPhillips also traded lower. Investors are focused on Exxon's Feb. 20 investor update and upcoming U.S. economic reports.
10 February 2026
···
1 … 157 158 159 160 161 … 1,394

Stock Market Today

  • Dollar Dips on Iran Peace Hopes, Oil Prices Rise
    April 27, 2026, 5:35 PM EDT. The U.S. dollar dipped from a 2.5-week high amid reports that Iran proposed reopening the Strait of Hormuz, a strategic oil passage, suggesting potential easing of US-Iran tensions. Axios reported the plan includes extending the ceasefire before nuclear talks, with the White House reviewing the proposal. Despite higher crude oil prices lifting inflation expectations-a factor that usually strengthens the dollar-uncertainty over US Federal Reserve interest rate moves and rate hike cutbacks in 2026 weighed on the currency. The dollar index fell 0.05%, while the euro saw modest gains supported by dollar weakness but constrained by weak German consumer and business confidence. The yen weakened slightly amid Japan's rising stock market and higher bond yields. Markets now price near zero chance of a Fed rate hike at this week's meeting.

Latest article

3I/ATLAS Comet’s Strange Water Points To A Birthplace Unlike Our Solar System

3I/ATLAS Comet’s Strange Water Points To A Birthplace Unlike Our Solar System

27 April 2026
Astronomers using ALMA have measured deuterated water in interstellar comet 3I/ATLAS, finding a deuterium-to-hydrogen ratio over 40 times higher than Earth’s oceans. The result indicates the comet formed in a much colder environment than the early solar system. The data were collected just after the comet’s perihelion as it now leaves the solar system.
Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

27 April 2026
Oruka Therapeutics reported its experimental psoriasis drug ORKA-001 achieved complete skin clearance in 63.5% of patients at 16 weeks. Shares jumped 10.5% to $76.39 before the company launched a $500 million public offering. No serious adverse events were reported in the trial. ORKA-001 is being developed as a long-acting injectable, with annual dosing possible.
Go toTop